A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
Status:
Recruiting
Trial end date:
2027-10-01
Target enrollment:
Participant gender:
Summary
Multicenter trial on the effect of the GnRH analogue leuprorelin on the growth of total liver
volume in pre-menopausal women with very severe polycystic liver disease who, despite
available therapy, experience growth and are heading for liver transplantation.